ABL Bio (Korea) Performance
298380 Stock | KRW 26,000 400.00 1.52% |
On a scale of 0 to 100, ABL Bio holds a performance score of 7. The firm shows a Beta (market volatility) of 0.25, which signifies not very significant fluctuations relative to the market. As returns on the market increase, ABL Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding ABL Bio is expected to be smaller as well. Please check ABL Bio's semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and standard deviation , to make a quick decision on whether ABL Bio's price patterns will revert.
Risk-Adjusted Performance
7 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in ABL Bio are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, ABL Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Total Cashflows From Investing Activities | 20.2 B |
ABL |
ABL Bio Relative Risk vs. Return Landscape
If you would invest 2,200,000 in ABL Bio on January 31, 2024 and sell it today you would earn a total of 400,000 from holding ABL Bio or generate 18.18% return on investment over 90 days. ABL Bio is generating 0.3414% of daily returns and assumes 3.7376% volatility on return distribution over the 90 days horizon. Simply put, 33% of stocks are less volatile than ABL, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
Risk |
ABL Bio Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ABL Bio's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ABL Bio, and traders can use it to determine the average amount a ABL Bio's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0913
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | 298380 | |||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
3.74 actual daily | 33 67% of assets are more volatile |
Expected Return
0.34 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
0.09 actual daily | 7 93% of assets perform better |
Based on monthly moving average ABL Bio is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ABL Bio by adding it to a well-diversified portfolio.
ABL Bio Fundamentals Growth
ABL Stock prices reflect investors' perceptions of the future prospects and financial health of ABL Bio, and ABL Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on ABL Stock performance.
Return On Equity | 5.6 | |||
Return On Asset | -0.31 | |||
Operating Margin | (6.16) % | |||
Current Valuation | 866.33 B | |||
Shares Outstanding | 45.3 M | |||
Price To Sales | 101.38 X | |||
Revenue | 5.33 B | |||
EBITDA | (53.58 B) | |||
Cash And Equivalents | 21.59 B | |||
Total Debt | 72.32 M | |||
Debt To Equity | 1.40 % | |||
Cash Flow From Operations | (40.61 B) | |||
Total Asset | 65.45 B | |||
About ABL Bio Performance
To evaluate ABL Bio Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when ABL Bio generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare ABL Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand ABL Bio market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents ABL's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. ABL Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.Things to note about ABL Bio performance evaluation
Checking the ongoing alerts about ABL Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ABL Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.ABL Bio had very high historical volatility over the last 90 days | |
The company reported the revenue of 5.33 B. Net Loss for the year was (43.56 B) with profit before overhead, payroll, taxes, and interest of 8.06 B. | |
ABL Bio has accumulated about 21.59 B in cash with (40.61 B) of positive cash flow from operations. | |
Roughly 32.0% of the company shares are owned by insiders or employees |
- Analyzing ABL Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ABL Bio's stock is overvalued or undervalued compared to its peers.
- Examining ABL Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ABL Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ABL Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ABL Bio's stock. These opinions can provide insight into ABL Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in ABL Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in nation. Note that the ABL Bio information on this page should be used as a complementary analysis to other ABL Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for ABL Stock analysis
When running ABL Bio's price analysis, check to measure ABL Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABL Bio is operating at the current time. Most of ABL Bio's value examination focuses on studying past and present price action to predict the probability of ABL Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABL Bio's price. Additionally, you may evaluate how the addition of ABL Bio to your portfolios can decrease your overall portfolio volatility.
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |